| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.563 | 0.004 | 0.563 | Interleukin 2 agonist | 0.541 0.005 CID_154700121 | ||
| 0.555 | 0.005 | 0.555 | P-glycoprotein inhibitor | 0.489 0.009 CID_154700121 | ||
| 0.516 | 0.029 | 0.535 | Immunosuppressant | 0.535 0.024 CID_154700121 | CID_154700121 | |
| 0.469 | 0.05 | 0.506 | Antibacterial | 0.506 0.039 CID_154700121 | CID_154700121 | |
| 0.46 | 0.045 | 0.471 | Calcium channel L-type activator | 0.471 0.04 CID_154700121 | CID_154700121 | |
| 0.391 | 0.02 | 0.391 | Sodium/bile acid cotransporter inhibitor | 0.378 0.025 CID_154700121 | ||
| 0.415 | 0.046 | 0.47 | Antithrombotic | 0.47 0.034 CID_154700121 | CID_154700121 | |
| 0.364 | 0.004 | 0.364 | ATPase inhibitor | 0.244 0.015 CID_154700121 | ||
| 0.36 | 0.026 | 0.36 | Interleukin agonist | 0.335 0.033 CID_154700121 | ||
| 0.342 | 0.037 | 0.358 | Insulysin inhibitor | 0.358 0.031 CID_154700121 | CID_154700121 | |
| 0.296 | 0.025 | 0.396 | Thrombolytic | 0.396 0.011 CID_154700121 | CID_154700121 | |
| 0.27 | 0.002 | 0.27 | Cyclophilin A inhibitor | 0.238 0.002 CID_154700121 | ||
| 0.253 | 0.008 | 0.257 | Nav1.4 sodium channel blocker | 0.257 0.007 CID_154700121 | CID_154700121 | |
| 0.251 | 0.026 | 0.251 | NOS3 expression enhancer | 0.175 0.053 CID_154700121 | ||
| 0.229 | 0.009 | 0.229 | CXC chemokine 4 receptor antagonist | 0.215 0.009 CID_154700121 | ||
| 0.276 | 0.062 | 0.276 | Platelet antagonist | 0.223 0.086 CID_154700121 | ||
| 0.21 | 0.015 | 0.258 | Cathepsin G inhibitor | 0.258 0.012 CID_154700121 | CID_154700121 | |
| 0.187 | 0.008 | 0.187 | Somatostatin 1 agonist | 0.176 0.009 CID_154700121 | ||
| 0.197 | 0.031 | 0.199 | Cell wall synthesis inhibitor | 0.199 0.03 CID_154700121 | CID_154700121 | |
| 0.21 | 0.049 | 0.243 | Anticoagulant | 0.243 0.04 CID_154700121 | CID_154700121 | |
| 0.17 | 0.012 | 0.233 | CDC-like kinase 3 inhibitor | 0.233 0.005 CID_154700121 | CID_154700121 | |
| 0.166 | 0.013 | 0.166 | Chymotrypsin inhibitor | 0.16 0.015 CID_154700121 | ||
| 0.152 | 0.014 | 0.224 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.224 0.005 CID_154700121 | CID_154700121 | |
| 0.136 | 0.004 | 0.136 | Growth hormone secretagogue receptor agonist | 0.127 0.004 CID_154700121 | ||
| 0.248 | 0.116 | 0.248 | Immunomodulator | 0.211 0.151 CID_154700121 | ||
| 0.146 | 0.02 | 0.171 | Interleukin 2 antagonist | 0.171 0.012 CID_154700121 | CID_154700121 | |
| 0.129 | 0.006 | 0.129 | Melanocortin 5 antagonist | 0.033 0.014 CID_154700121 | ||
| 0.135 | 0.017 | 0.139 | Factor XII inhibitor | 0.139 0.016 CID_154700121 | CID_154700121 | |
| 0.148 | 0.031 | 0.148 | Antineoplastic antibiotic | 0.146 0.032 CID_154700121 | ||
| 0.119 | 0.004 | 0.132 | GHS receptor agonist | 0.132 0.004 CID_154700121 | CID_154700121 | |
| 0.117 | 0.012 | 0.117 | Polo-like kinase-2 inhibitor | |||
| 0.152 | 0.048 | 0.152 | Interleukin 4 antagonist | 0.147 0.053 CID_154700121 | ||
| 0.156 | 0.057 | 0.166 | Histone deacetylase SIRT1 inhibitor | 0.166 0.049 CID_154700121 | CID_154700121 | |
| 0.249 | 0.15 | 0.249 | Calpain 2 inhibitor | 0.236 0.16 CID_154700121 | ||
| 0.112 | 0.015 | 0.112 | GP IIb/IIIa receptor antagonist | 0.086 0.02 CID_154700121 | ||
| 0.305 | 0.211 | 0.305 | Antiinflammatory | |||
| 0.098 | 0.007 | 0.098 | Somatostatin 1 antagonist | 0.085 0.008 CID_154700121 | ||
| 0.103 | 0.016 | 0.103 | Integrin antagonist | 0.043 0.029 CID_154700121 | ||
| 0.094 | 0.01 | 0.094 | Oxytocin antagonist | 0.091 0.011 CID_154700121 | ||
| 0.089 | 0.008 | 0.089 | Kallikrein 7 inhibitor | 0.087 0.009 CID_154700121 | ||
| 0.093 | 0.013 | 0.093 | Neurokinin antagonist | |||
| 0.084 | 0.007 | 0.084 | Antiviral (Hepatitis D) | 0.081 0.008 CID_154700121 | ||
| 0.086 | 0.012 | 0.096 | Erythropoietin receptor agonist | 0.096 0.011 CID_154700121 | CID_154700121 | |
| 0.082 | 0.013 | 0.082 | Neurokinin 2 antagonist | 0.066 0.017 CID_154700121 | ||
| 0.079 | 0.014 | 0.079 | Melanocortin antagonist | 0.059 0.021 CID_154700121 | ||
| 0.07 | 0.009 | 0.07 | Somatostatin 5 antagonist | 0.057 0.011 CID_154700121 | ||
| 0.061 | 0.001 | 0.061 | Immunosuppressant Cyclosporine-like | 0.055 0.001 CID_154700121 | ||
| 0.1 | 0.039 | 0.124 | Acetylcholine nicotinic antagonist | 0.124 0.029 CID_154700121 | CID_154700121 | |
| 0.122 | 0.063 | 0.176 | Proteasome inhibitor | 0.176 0.034 CID_154700121 | CID_154700121 | |
| 0.154 | 0.097 | 0.154 | Catenin beta inhibitor | |||
| 0.067 | 0.01 | 0.067 | Somatostatin 2 antagonist | 0.059 0.012 CID_154700121 | ||
| 0.064 | 0.011 | 0.068 | Nicotinic receptor beta4 subunit antagonist | 0.068 0.01 CID_154700121 | CID_154700121 | |
| 0.066 | 0.012 | 0.066 | Oxytocin agonist | 0.064 0.014 CID_154700121 | ||
| 0.064 | 0.015 | 0.086 | Histone deacetylase 8 inhibitor | 0.086 0.009 CID_154700121 | CID_154700121 | |
| 0.181 | 0.133 | 0.227 | Calpain inhibitor | 0.227 0.088 CID_154700121 | CID_154700121 | |
| 0.088 | 0.04 | 0.088 | CC chemokine 5 receptor agonist | 0.083 0.055 CID_154700121 | ||
| 0.091 | 0.044 | 0.095 | 3C-Like protease (SARS coronavirus) inhibitor | 0.095 0.039 CID_154700121 | CID_154700121 | |
| 0.081 | 0.035 | 0.097 | Neuronal nicotinic receptor antagonist | 0.097 0.026 CID_154700121 | CID_154700121 | |
| 0.043 | 0.001 | 0.043 | Calcineurin inhibitor | 0.038 0.002 CID_154700121 | ||
| 0.058 | 0.017 | 0.058 | Growth hormone release inhibitor | 0.055 0.018 CID_154700121 | ||
| 0.046 | 0.005 | 0.046 | Integrin beta5 antagonist | 0.041 0.006 CID_154700121 | ||
| 0.125 | 0.088 | 0.174 | Neurotrophic factor | 0.174 0.041 CID_154700121 | CID_154700121 | |
| 0.045 | 0.008 | 0.045 | Somatostatin 4 antagonist | 0.036 0.01 CID_154700121 | ||
| 0.052 | 0.015 | 0.052 | Substance P antagonist | |||
| 0.11 | 0.074 | 0.156 | Microtubule formation inhibitor | 0.156 0.034 CID_154700121 | CID_154700121 | |
| 0.043 | 0.01 | 0.044 | Growth factor receptor-bound protein 2 antagonist | 0.044 0.009 CID_154700121 | CID_154700121 | |
| 0.108 | 0.076 | 0.108 | Cell adhesion inhibitor | 0.099 0.09 CID_154700121 | ||
| 0.049 | 0.019 | 0.049 | Integrin alpha5beta1 antagonist | 0.048 0.02 CID_154700121 | ||
| 0.038 | 0.008 | 0.038 | Motilin receptor antagonist | 0.038 0.008 CID_154700121 | ||
| 0.091 | 0.06 | 0.091 | Polo-like kinase-1 inhibitor | |||
| 0.039 | 0.01 | 0.039 | Urotensin II agonist | 0.036 0.011 CID_154700121 | ||
| 0.035 | 0.008 | 0.035 | Somatostatin 3 antagonist | 0.027 0.01 CID_154700121 | ||
| 0.068 | 0.043 | 0.071 | Glucagon-like peptide 1 agonist | 0.071 0.041 CID_154700121 | CID_154700121 | |
| 0.049 | 0.024 | 0.049 | Melanocortin 4 antagonist | 0.047 0.025 CID_154700121 | ||
| 0.1 | 0.077 | 0.105 | Polo-like kinase-4 inhibitor | 0.105 0.071 CID_154700121 | CID_154700121 | |
| 0.144 | 0.122 | 0.198 | Interleukin antagonist | 0.198 0.085 CID_154700121 | CID_154700121 | |
| 0.064 | 0.044 | 0.079 | Opioid delta receptor antagonist | 0.079 0.037 CID_154700121 | CID_154700121 | |
| 0.037 | 0.018 | 0.037 | Somatostatin agonist | 0.029 0.025 CID_154700121 | ||
| 0.031 | 0.013 | 0.031 | Antidiuretic hormone agonist | 0.03 0.014 CID_154700121 | ||
| 0.049 | 0.033 | 0.049 | CC chemokine receptor 2B antagonist | |||
| 0.026 | 0.01 | 0.026 | Integrin beta3 antagonist | 0.018 0.016 CID_154700121 | ||
| 0.034 | 0.021 | 0.034 | Vasopressin 2 antagonist | 0.033 0.023 CID_154700121 | ||
| 0.029 | 0.018 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.016 CID_154700121 | CID_154700121 | |
| 0.023 | 0.012 | 0.023 | Integrin alpha4beta7 antagonist | |||
| 0.081 | 0.07 | 0.081 | Hematopoietic | |||
| 0.025 | 0.016 | 0.025 | Growth hormone releasing factor antagonist | 0.023 0.017 CID_154700121 | ||
| 0.029 | 0.02 | 0.029 | Vasopressin 1A agonist | 0.029 0.018 CID_154700121 | ||
| 0.193 | 0.184 | 0.327 | Vasodilator, peripheral | 0.327 0.084 CID_154700121 | CID_154700121 | |
| 0.091 | 0.084 | 0.096 | mTOR complex 1 inhibitor | 0.096 0.071 CID_154700121 | CID_154700121 | |
| 0.052 | 0.047 | 0.055 | Kallikrein 1 inhibitor | 0.055 0.042 CID_154700121 | CID_154700121 | |
| 0.039 | 0.034 | 0.039 | Leukocyte elastase inhibitor | |||
| 0.026 | 0.021 | 0.026 | Melanocortin 3 antagonist | |||
| 0.038 | 0.033 | 0.038 | Neurokinin 1 antagonist | |||
| 0.049 | 0.044 | 0.049 | Elastase inhibitor | 0.048 0.046 CID_154700121 | ||
| 0.234 | 0.232 | 0.26 | Apoptosis agonist | 0.26 0.204 CID_154700121 | CID_154700121 | |
| 0.033 | 0.031 | 0.033 | Melanocortin 1 antagonist | |||
| 0.021 | 0.018 | 0.021 | Vasopressin 1 agonist | 0.021 0.017 CID_154700121 | ||
| 0.076 | 0.075 | 0.087 | Opioid antagonist | 0.087 0.061 CID_154700121 | CID_154700121 | |
| 0.038 | 0.039 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | 0.045 0.03 CID_154700121 | CID_154700121 | |
| 0.029 | 0.03 | 0.034 | Histone deacetylase 2 inhibitor | 0.034 0.023 CID_154700121 | CID_154700121 | |
| 0.143 | 0.152 | 0.204 | Histone acetyltransferase inhibitor | 0.204 0.064 CID_154700121 | CID_154700121 | |
| 0.053 | 0.062 | 0.061 | Opioid mu receptor antagonist | 0.061 0.053 CID_154700121 | CID_154700121 | |
| 0.023 | 0.032 | 0.029 | Histone deacetylase class IV inhibitor | 0.029 0.024 CID_154700121 | CID_154700121 | |
| 0.023 | 0.032 | 0.029 | Histone deacetylase 11 inhibitor | 0.029 0.024 CID_154700121 | CID_154700121 | |
| 0.125 | 0.14 | 0.143 | Angiogenesis stimulant | 0.143 0.127 CID_154700121 | CID_154700121 | |
| 0.137 | 0.157 | 0.151 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.151 0.132 CID_154700121 | CID_154700121 | |
| 0.16 | 0.185 | 0.188 | DNA synthesis inhibitor | 0.188 0.142 CID_154700121 | CID_154700121 | |
| 0.149 | 0.184 | 0.171 | 5 Hydroxytryptamine release stimulant | 0.171 0.151 CID_154700121 | CID_154700121 | |
| 0.095 | 0.134 | 0.18 | Protein kinase stimulant | 0.18 0.05 CID_154700121 | CID_154700121 | |
| 0.161 | 0.213 | 0.224 | Transcription factor NF kappa B inhibitor | 0.224 0.147 CID_154700121 | CID_154700121 | |
| 0.085 | 0.152 | 0.183 | CDC-like kinase 1 inhibitor | 0.183 0.046 CID_154700121 | CID_154700121 | |
| 0.039 | 0.112 | 0.057 | NMDA receptor agonist | 0.057 0.052 CID_154700121 | CID_154700121 | |
| 0.107 | 0.183 | 0.22 | Antimitotic | 0.22 0.074 CID_154700121 | CID_154700121 | |
| 0.044 | 0.186 | 0.076 | Antineoplastic alkaloid | 0.076 0.07 CID_154700121 | CID_154700121 | |
| 0.02 | 0.208 | 0.071 | HIV-1 reverse transcriptase inhibitor | 0.071 0.048 CID_154700121 | CID_154700121 | |
| 0.012 | 0.287 | 0.049 | Plasminogen activator inhibitor antagonist | 0.049 0.034 CID_154700121 | CID_154700121 | |
| 0.007 | 0.323 | 0.021 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.021 0.012 CID_154700121 | CID_154700121 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |